Search

Home
Staff
Sarah Al Ashmori Theophile Bigirumurame Andy Bryant Thomas Chadwick Svetlana Cherlin Mike Cole Holly Fisher Tony Fouweather Shaun Hiu Dorcas Kareithi Ann Breeze Konkoth Nan Lin Jingky Lozano-Kuehne Helen Mossop Ellen Moss Jérémie Nsengimana Vicky Ryan Marzieh Shahmandi Moha Shojaei Dawn Teare James Wason Faye Williamson Nina Wilson Sylvia Zhang
PhD students
Ruqayya Azher Nicole Cizauskas Laura Etfer Niamh Fitzgerald Raiann Hamshaw Aritra Mukherjee Pela Okorie Samuel Sarkodie Lou Whitehead
Methodology research
Overview Adaptive designs Master protocols Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures Leveraging External Information Precision Medicine Clinical Trials
Contact

Tweddle DA

Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival
Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival
High Frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma
p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age

Published with Wowchemy — the free, open source website builder that empowers creators.